Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Ophthalmology
Study Phase : Preclinical
Recipient : Famar
Deal Size : Undisclosed
Deal Type : Collaboration
Famar & D-Sight Partner for CMC Development & Clinical Batch Manufacturing
Details : The collaboration aims to accelerate the development and production of clinical batches for D-Sight’s eye drops solution. It is being evaluated for the treatment of diabetic retinopathy.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
May 13, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Ophthalmology
Highest Development Status : Preclinical
Recipient : Famar
Deal Size : Undisclosed
Deal Type : Collaboration